Vaccinex, Inc. Files 8-K Report
Ticker: VCNX · Form: 8-K · Filed: Mar 27, 2024 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $7.77, $1.5 million, $1.25 million, $1.75 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Corporate Update
TL;DR
Vaccinex Inc. filed an 8-K, standard corporate update. Nothing major disclosed in this snippet.
AI Summary
On March 27, 2024, Vaccinex, Inc. filed an 8-K report. The filing indicates that the company is involved in the pharmaceutical preparations industry, with its principal executive offices located in Rochester, New York. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing serves as a public record of Vaccinex, Inc.'s corporate activities, providing transparency for investors and stakeholders regarding its status and industry.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain information that would indicate a specific risk to investors.
Key Numbers
- 001-38624 — Commission File Number (Identifies the company's filing with the SEC)
- 16-1603202 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- Rochester, New York (location) — Principal executive offices location
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Vaccinex, Inc.?
Vaccinex, Inc. is in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code 2834.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 27, 2024.
Where are Vaccinex, Inc.'s principal executive offices located?
Vaccinex, Inc.'s principal executive offices are located at 1895 Mount Hope Avenue, Rochester, New York, 14620.
What is Vaccinex, Inc.'s Commission File Number?
Vaccinex, Inc.'s Commission File Number is 001-38624.
What is the IRS Employer Identification Number for Vaccinex, Inc.?
The IRS Employer Identification Number for Vaccinex, Inc. is 16-1603202.
Filing Stats: 682 words · 3 min read · ~2 pages · Grade level 13.7 · Accepted 2024-03-27 08:39:00
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share VCNX Nasdaq Capital Marke
- $7.77 — rivate placement at a combined price of $7.77 per Share and Common Warrant (the "Offe
- $1.5 million — gregate gross proceeds of approximately $1.5 million. The Purchase Agreement prohibits the
- $1.25 million — s for aggregate gross proceeds of up to $1.25 million and (ii) a charitable organization of e
- $1.75 million — s for aggregate gross proceeds of up to $1.75 million. Prior to entering into the Purchase
- $4,391,000 — , 2023 related to the offering of up to $4,391,000 of shares of Common Stock pursuant to a
Filing Documents
- d768315d8k.htm (8-K) — 24KB
- 0001193125-24-078295.txt ( ) — 140KB
- vcnx-20240327.xsd (EX-101.SCH) — 3KB
- vcnx-20240327_lab.xml (EX-101.LAB) — 17KB
- vcnx-20240327_pre.xml (EX-101.PRE) — 11KB
- d768315d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Vaccinex, Inc. Date: March 27, 2024 By: /s/ Maurice Zauderer Maurice Zauderer Chief Executive Officer